ChemChina's Syngenta Deal Divides Moody's, Fitch on Debt Risks

  • ChemChina debt-to-equity ratio was at 260% as of Sept. 30
  • Similar gauge for ChemChina's international peers was 61%

China National Chemical Corp.’s $43 billion deal to buy Syngenta AG is dividing credit raters on whether the company’s acquisition spree will load it with too much debt.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.